Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 10,038
-27 (-0.26%)
Nov 4, 2026, 3:29 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.66 trillion as of November 4, 2026. It is the 881st most valuable company in the world and the 34th biggest in India. Its market cap has increased by 47.52% in one year.
Market Cap
2.66T
Enterprise Value
2.63T
Revenue
112.30B
Global Rank
Country Rank
#34 India
PE Ratio
91.07
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.66T, an increase of 130,807.39%. That is a compound annual growth rate of 35.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 2.66T | 57.02% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.25T |
| Laurus Labs | 1.24T |
| Zydus Lifesciences | 1.24T |
| Cipla | 1.12T |
| Mankind Pharma | 1.02T |
| Aurobindo Pharma | 968.82B |
| Glenmark Pharmaceuticals | 675.59B |
| Alkem Laboratories | 621.68B |